Cytokinetics drug Myqorzo meets twin efficacy goals in study
Myqorzo significantly improved heart failure symptoms and cardiovascular fitness in patients with genetic heart disease.
Myqorzo significantly improved heart failure symptoms and cardiovascular fitness in patients with genetic heart disease.